EU waives Takeda/Shire merger commitments

The European Commission has waived the conditions it imposed on Takeda’s 2018 takeover of rival Shire due to “permanent, significant and unforeseeable developments” that occurred as the drugmaker attempted to complete its required divestiture.


Get unlimited access to all Global Competition Review content